| Methods | Randomised, parallel group unblinded study. Follow‐up for 12 months. | |
| Participants | 38 drug naive participants, all with typical absence seizures, age 3 to 13 years. | |
| Interventions | Monotherapy with VPS or LTG. | |
| Outcomes | Total seizures freedom defined by clinical reports, 24 hours EEG and hyperventilation test. | |
| Notes | ||
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Low risk | Random sequence was generated using a randomisation code. |
| Allocation concealment (selection bias) | Low risk | Central allocation. |
| Blinding (performance bias and detection bias) All outcomes | High risk | No blinding. It is not stated whether tables of VPA and LTG were indistinguishable. |
| Blinding of participants and personnel (performance bias) All outcomes | High risk | No blinding. It is not stated whether tables of VPA and LTG were indistinguishable. |
| Blinding of outcome assessment (detection bias) All outcomes | High risk | No blinding. It is not stated whether tables of VPA and LTG were indistinguishable. |
| Incomplete outcome data (attrition bias) All outcomes | Low risk | No missing outcome data. |
| Selective reporting (reporting bias) | Low risk | The study protocol is not available but it is clear that the published reports include all expected outcomes. |